Literature DB >> 24163379

The cyclin-dependent kinase inhibitor p16INK4a physically interacts with transcription factor Sp1 and cyclin-dependent kinase 4 to transactivate microRNA-141 and microRNA-146b-5p spontaneously and in response to ultraviolet light-induced DNA damage.

Huda H Al-Khalaf1, Peer Mohideen, Shreeram C Nallar, Dhananjaya V Kalvakolanu, Abdelilah Aboussekhra.   

Abstract

p16(INK4a) is a tumor suppressor protein involved in several stress-related cellular responses, including apoptosis. Recent lines of evidence indicate that p16(INK4a) is also a modulator of gene expression. However, the molecular mechanisms underlying this novel function are still obscure. Here, we present clear evidence that p16(INK4a) modulates the levels of various microRNAs, with marked positive effect on miR-141 and miR-146b-5p. This effect is mediated through the formation of the p16-CDK4-Sp1 heterocomplex, which binds to Sp1 consensus-binding motifs present in the promoters of miR-141 and miR-146b-5p, and it enables their transcription. In addition, we have shown that p16(INK4a) interacts with Sp1 through the fourth ankyrin repeat, which is crucial for Sp1 binding to the miR-141 and miR-146b-5p promoters and their transcriptional activation. The physiological importance of this association was revealed by the inability of cancer-related p16(INK4a) mutants to interact with Sp1. Moreover, we have shown p16-CDK4-Sp1-dependent up-regulation of miR-141 and miR-146b-5p following UV light-induced DNA damage and the role of these two microRNAs in mediating p16-related induction of apoptosis in response to this genotoxic stress. Together, these results indicate that p16(INK4a) associates with CDK4 not only to inhibit the cell cycle but also to enable the transcription of two important onco-microRNAs, which act as downstream effectors.

Entities:  

Keywords:  Protein Complexes; Protein-DNA Interaction; Signaling; Tumor suppressor gene; shRNA

Mesh:

Substances:

Year:  2013        PMID: 24163379      PMCID: PMC3853297          DOI: 10.1074/jbc.M113.512640

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  51 in total

Review 1.  p16(MTS-1/CDKN2/INK4a) in cancer progression.

Authors:  J W Rocco; D Sidransky
Journal:  Exp Cell Res       Date:  2001-03-10       Impact factor: 3.905

Review 2.  RB and cell cycle progression.

Authors:  C Giacinti; A Giordano
Journal:  Oncogene       Date:  2006-08-28       Impact factor: 9.867

Review 3.  The role of Sp1 and Sp3 in normal and cancer cell biology.

Authors:  Lin Li; James R Davie
Journal:  Ann Anat       Date:  2010-08-06       Impact factor: 2.698

4.  NF-kappaB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses.

Authors:  Konstantin D Taganov; Mark P Boldin; Kuang-Jung Chang; David Baltimore
Journal:  Proc Natl Acad Sci U S A       Date:  2006-08-02       Impact factor: 11.205

Review 5.  MicroRNAs in the pathogenesis of cancer.

Authors:  Francesca Lovat; Nicola Valeri; Carlo M Croce
Journal:  Semin Oncol       Date:  2011-12       Impact factor: 4.929

Review 6.  Cyclin D-dependent kinases, INK4 inhibitors and cancer.

Authors:  Sagrario Ortega; Marcos Malumbres; Mariano Barbacid
Journal:  Biochim Biophys Acta       Date:  2002-03-14

7.  Proteomic analysis of p16ink4a-binding proteins.

Authors:  Elielson Souza-Rodrígues; Josep M Estanyol; Erica Friedrich-Heineken; Eva Olmedo; Jorge Vera; Nuria Canela; Sonia Brun; Neus Agell; Ulrich Hübscher; Oriol Bachs; Montserrat Jaumot
Journal:  Proteomics       Date:  2007-11       Impact factor: 3.984

8.  The tumor suppressor p16(INK4a) gene is a regulator of apoptosis induced by ultraviolet light and cisplatin.

Authors:  Mai A Al-Mohanna; Pulicat S Manogaran; Zuha Al-Mukhalafi; Khaled A Al-Hussein; Abdelilah Aboussekhra
Journal:  Oncogene       Date:  2004-01-08       Impact factor: 9.867

9.  Retinoblastoma-protein-dependent cell-cycle inhibition by the tumour suppressor p16.

Authors:  J Lukas; D Parry; L Aagaard; D J Mann; J Bartkova; M Strauss; G Peters; J Bartek
Journal:  Nature       Date:  1995-06-08       Impact factor: 49.962

10.  Sp1 expression regulates lung tumor progression.

Authors:  T-I Hsu; M-C Wang; S-Y Chen; Y-M Yeh; W-C Su; W-C Chang; J-J Hung
Journal:  Oncogene       Date:  2011-12-12       Impact factor: 9.867

View more
  15 in total

1.  Obesity and p16INK4A Downregulation Activate Breast Adipocytes and Promote Their Protumorigenicity.

Authors:  Huda H Al-Khalaf; Mrad Amir; Falah Al-Mohanna; Asma Tulbah; Adher Al-Sayed; Abdelilah Aboussekhra
Journal:  Mol Cell Biol       Date:  2017-08-11       Impact factor: 4.272

2.  p16INK4A enhances the transcriptional and the apoptotic functions of p53 through DNA-dependent interaction.

Authors:  Huda H Al-Khalaf; Shreeram C Nallar; Dhananjaya V Kalvakolanu; Abdelilah Aboussekhra
Journal:  Mol Carcinog       Date:  2017-03-06       Impact factor: 4.784

3.  MicroRNA-141 and microRNA-146b-5p inhibit the prometastatic mesenchymal characteristics through the RNA-binding protein AUF1 targeting the transcription factor ZEB1 and the protein kinase AKT.

Authors:  Huda H Al-Khalaf; Abdelilah Aboussekhra
Journal:  J Biol Chem       Date:  2014-09-26       Impact factor: 5.157

Review 4.  Clinical implications of miRNAs in the pathogenesis, diagnosis and therapy of pancreatic cancer.

Authors:  Satyanarayana Rachagani; Muzafar A Macha; Nicholas Heimann; Parthasarathy Seshacharyulu; Dhanya Haridas; Seema Chugh; Surinder K Batra
Journal:  Adv Drug Deliv Rev       Date:  2014-10-23       Impact factor: 15.470

5.  p16 Represses DNA Damage Repair via a Novel Ubiquitin-Dependent Signaling Cascade.

Authors:  David P Molkentine; Jessica M Molkentine; Kathleen A Bridges; David R Valdecanas; Annika Dhawan; Reshub Bahri; Andrew J Hefner; Manish Kumar; Liangpeng Yang; Mohamed Abdelhakiem; Phillip M Pifer; Vlad Sandulache; Aakash Sheth; Beth M Beadle; Howard D Thames; Kathryn A Mason; Curtis R Pickering; Raymond E Meyn; Heath D Skinner
Journal:  Cancer Res       Date:  2022-03-01       Impact factor: 13.312

6.  Interleukin-8 Dedifferentiates Primary Human Luminal Cells to Multipotent Stem Cells.

Authors:  Huda H Al-Khalaf; Hazem Ghebeh; Salma M Wakil; Falah Al-Mohanna; Abdelilah Aboussekhra
Journal:  Mol Cell Biol       Date:  2020-04-13       Impact factor: 4.272

7.  MiR-141 Inhibits Gastric Cancer Proliferation by Interacting with Long Noncoding RNA MEG3 and Down-Regulating E2F3 Expression.

Authors:  Xiaoying Zhou; Guoping Ji; Xiquan Ke; Huiyuan Gu; Wujuan Jin; Guoxin Zhang
Journal:  Dig Dis Sci       Date:  2015-08-02       Impact factor: 3.199

8.  Novel Double-Hit Model of Radiation and Hyperoxia-Induced Oxidative Cell Damage Relevant to Space Travel.

Authors:  Ralph A Pietrofesa; Anastasia Velalopoulou; Stacey L Lehman; Evguenia Arguiri; Pantelis Solomides; Cameron J Koch; Om P Mishra; Constantinos Koumenis; Thomas J Goodwin; Melpo Christofidou-Solomidou
Journal:  Int J Mol Sci       Date:  2016-06-16       Impact factor: 5.923

Review 9.  CDK4/6 Inhibitors in Melanoma: A Comprehensive Review.

Authors:  Mattia Garutti; Giada Targato; Silvia Buriolla; Lorenza Palmero; Alessandro Marco Minisini; Fabio Puglisi
Journal:  Cells       Date:  2021-05-28       Impact factor: 6.600

10.  Effect of Iodine Intake on p14ARF and p16INK4a Expression in Thyroid Papillary Carcinoma in Rats.

Authors:  Ruimei Sun; Jinde Wang; Xiaojiang Li; Lei Li; Jie Yang; Yanxin Ren; Yan Xi; Chuanzheng Sun
Journal:  Med Sci Monit       Date:  2015-08-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.